Y
Youri Glupczynski
Researcher at Université catholique de Louvain
Publications - 293
Citations - 13159
Youri Glupczynski is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Helicobacter pylori & Imipenem. The author has an hindex of 58, co-authored 283 publications receiving 12178 citations. Previous affiliations of Youri Glupczynski include Catholic University of Leuven & Université libre de Bruxelles.
Papers
More filters
Journal ArticleDOI
Aminoglycosides: Activity and Resistance
TL;DR: Aminoglycosides are highly potent, broad-spectrum antibiotics with many desirable properties for the treatment of life-threatening infections and have a history marked by the successive introduction of a series of milestone compounds.
Journal ArticleDOI
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Rafael Cantón,Murat Akova,Yehuda Carmeli,Christian G. Giske,Youri Glupczynski,Marek Gniadkowski,David M. Livermore,David M. Livermore,Vivi Miriagou,Thierry Naas,Gian Maria Rossolini,Ørjan Samuelsen,Harald Seifert,Neil Woodford,Patrice Nordmann +14 more
TL;DR: Rapid identification of colonized or infected patients and screening of carriers is possible, and will probably be effective for prevention of a scenario of endemicity, as now reported for extended-spectrum β-lactamase producers in all European countries.
Journal ArticleDOI
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Mégraud,Samuel Coenen,Ann Versporten,Manfred Kist,Manuel Lopez-Brea,Alexander M. Hirschl,Leif P. Andersen,Herman Goossens,Youri Glupczynski +8 more
TL;DR: In many countries the high rate of clarithromycin resistance no longer allows its empirical use in standard anti-H pylori regimens, so knowledge of outpatient antibiotic consumption may provide a simple tool to predict the susceptibility of H pyloris to quinolones and to macrolides and to adapt the treatment strategies.
Journal ArticleDOI
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
Narcisa Mesaros,Patrice Nordmann,Patrick Plésiat,M. Roussel-Delvallez,J. Van Eldere,Youri Glupczynski,Y. Van Laethem,Frédérique Jacobs,Patrick Lebecque,Anne Malfroot,P. M. Tulkens,F. Van Bambeke +11 more
TL;DR: Among broad-spectrum antibiotics in development, ceftobiprole, sitafloxacin and doripenem show interesting in-vitro activity, although the first two molecules have been evaluated in clinics only against Gram-positive organisms.
Journal ArticleDOI
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.
Hajo Grundmann,Hajo Grundmann,Corinna Glasner,Corinna Glasner,Barbara Albiger,David M. Aanensen,David M. Aanensen,Chris T Tomlinson,Arjana Tambic Andrasevic,Rafael Cantón,Yehuda Carmeli,Alexander W. Friedrich,Christian G. Giske,Christian G. Giske,Youri Glupczynski,Marek Gniadkowski,David M. Livermore,David M. Livermore,Patrice Nordmann,Patrice Nordmann,Laurent Poirel,Laurent Poirel,Gian Maria Rossolini,Harald Seifert,Alkiviadis Vatopoulos,Timothy R. Walsh,Neil Woodford,Dominique L Monnet,Andi Koraqi,Denada Lacej,Petra Apfalter,Rainer Hartl,Te-Din Huang,T. Strateva,Y. Marteva-Proevska,Iva Butic,Despo Pieridou-Bagatzouni,Panagiota Maikanti-Charalampous,Jaroslav Hrabak,Helena Zemlickova,Anette M. Hammerum,Lotte Jakobsen,Marina Ivanova,Anastasia Pavelkovich,Jari Jalava,Monica Osterblad,Laurent Dortet,Sophie Vaux,Martin Kaase,Sören Gatermann,Kyriaki Tryfinopoulou,Akos Toth,Laura Janvari,Teck Wee Boo,Elaine McGrath,Amos Adler,Annalisa Pantosti,Monica Monaco,Lul Raka,Arsim Kurti,Arta Balode,Mara Saule,Jolanta Miciuleviciene,Aiste Mierauskaite,Monique Perrin-Weniger,Paul Reichert,Nina Nestorova,Sonia Debattista,Gordana Mijovic,Milena Lopicic,Ørjan Samuelsen,Bjørg Haldorsen,Dorota Zabicka,E Literacka,Manuela Caniça,Vera Manageiro,Ana Kaftandzieva,Elena Trajkovska-Dokic,Maria Damian,Brandusa Elena Lixandru,Zora Jelesic,Anika Trudic,Milan Niks,Eva Schreterova,Mateja Pirs,Tjasa Cerar,Jesús Oteo,Belén Aracil,Christian Giske,Karin Sjostrom,D Gür,Asli Cakar,Katie L. Hopkins,Camilla Wiuff,Derek J. Brown +94 more
TL;DR: The development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals are reported.